OBN Press Releases


Wickham Labs Announces Upcoming Webinar on Microbiological Considerations in Cleanroom Validation

Wednesday, March 06, 2019 - Wickham Labs

Wickham Laboratories is proud to present a live webinar on 'Microbiological Considerations in Cleanroom Validation' conducted by our Microbiology Business Support Co-ordinator and one of our QC Laboratory Senior Technicians. Any contamination, microbiological or otherwise, is a major safety concern during the development of pharmaceuticals and medical devices. During this webinar our presenters will discuss the applicable grading systems & standards...

Read More

OBN Launches New Purchasing Platform to Provide E-Commerce Solution for its Members

Tuesday, February 19, 2019 - Rebecca Wilkes

Fisher Scientific is the official sponsor and primary preferred supplier to the OBN Purchasing Consortium Abingdon, UK; 19th February 2019 - OBN, the Membership organisation supporting the UK’s innovative life sciences companies, is pleased to announce today the launch of its new online Purchasing Platform.  The aim of the new Purchasing Platform, which can be accessed by OBN’s Full Members, Sponsors and Supporters, is to enable users to have a...

Read More

Microbiological Considerations in Cleanroom Validation: Application Note Published in European Pharmaceutical Review

Thursday, February 07, 2019 - Wickham Labs

Wickham Laboratories Ltd is delighted to announce our most recent technical article on, “Microbiological Considerations in Cleanroom Validation”, which has been featured in European Pharmaceutical Review’s December 2018 issue. Microbiological contamination is a major safety concern within the manufacturing and development of all pharmaceutical & medical devices. This article discusses how and why a cleanroom environment plays an important role...

Read More

OBN Announces the Success of 2nd Annual BioSeed® 2019

Tuesday, January 22, 2019 - Rebecca Wilkes

Abingdon, UK, 22 January 2019: – OBN (UK) Ltd, the membership organisation that supports the life sciences industry, is delighted to announce the success of their 2nd annual BioSeed® event held on Wednesday,16 January 2019, at Level 39 in Canary Wharf, London. The event was a great success and included a packed schedule of quickfire / 5minute presentations from 43 early stage European life sciences companies, who showcased a range of new technologies...

Read More

Article on In Vitro Methods Published in IBI

Thursday, January 10, 2019 - Wickham Labs

Wickham Laboratories are excited to announce their most recent publication on “The Importance of Testing for Pyrogens in Raw and In-Process Materials”, written by Section Head of Endotoxin and Cytotoxicity Testing, Sophie Bell.   The article, published by International Biopharmaceutical Industry (IBI) in their December issue, discusses the effects pyrogens can have on humans and focuses on the three different methods used to test for pyrogens...

Read More

OBN Appoints New Chairman and Non-Executive Director to Enhance Board Expertise

Wednesday, January 02, 2019 - Jonathan Rohll

Abingdon, UK: OBN, the membership organisation supporting the UK’s innovative life sciences companies, announces the following changes to its Board: Bill Fleming has been appointed the new Chairman of the Board of Directors, replacing Sally Waterman, who has served on the Board of Directors since 2014. Bill Fleming has strong management and board of director experience, having served on OBN’s Board as a Non-Executive Director since April 2017....

Read More

Wickham Laboratories to Exhibit at Pharmig 2018

Tuesday, November 06, 2018 - Wickham Labs

Wickham Laboratories will be exhibiting at Pharmig’s 26th annual conference held on the 28 and 29 November at the Belfry Hotel, Nottingham. This year’s event will bring together an array of industry experts and regulators to discuss the latest research and findings within the pharmaceutical microbiology industry. The conference programme will include the following topics among others: Water system biofilms Uses and applications of microbiological...

Read More

Leading AI-driven drug discovery company Exscientia expands to The Oxford Science Park

Thursday, November 01, 2018 - Rebecca Wilkes

Leading AI-driven drug discovery company Exscientia expands to The Oxford Science Park Facilities in The Schrödinger Building to bring together AI experts and biologists Oxford, UK, 1 November 2018 - In a key point in its growth strategy, Exscientia, the innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is expanding its Oxford presence to the new Schrödinger Building on The Oxford Science Park, one of...

Read More

Wickham Laboratories article on the Preservative Efficacy Test (PET) and Challenges in Preventing Microbial Growth

Wednesday, October 31, 2018 - Wickham Labs

Wickham Laboratories are excited to announce their latest article being published by Cleanroom Technology in November, “Testing Preservatives with PET”, written by Microbiology Business Support Coordinator, Tasmin Stock. The article discusses specific challenges we face when preventing microbial growth, considering the regulations & validations of drug products and why efficacy is the main concern in active ingredients. An excerpt of this article...

Read More

OBN Awards 2018 – Winners Recognised at Industry Leading Event

Friday, October 12, 2018 - Rebecca Wilkes

Abingdon, UK: OBN (UK) Ltd, the membership organisation that supports the life sciences industry, is delighted to announce the winners of the 2018 OBN Awards. The Awards, which are in their 10th year, celebrate the best of UK life sciences – from outstanding scientific innovation within biotech, medtech, digital, synthetic biology, to the companies that support the industry and the fundraisers that make it happen.  This year’s event hosted an audience...

Read More

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.